Mabion’s article about RFP process named one of the Top 10 Industry Insights of 2025 by Outsourced Pharma

• Mabion’s article, Optimize Your RFP To Ensure Successful Biologic Development, was recognized as one of the Top 10 of 2025 Industry Insights.
• The RFP process is a structured procurement method. Mabion team presents an effective way to optimize it and achieve cooperation faster.

Outsourced Pharma announced the winners of the Top 10 Of 2025 in the Best Materials of Industry Insights category. Mabion’s article was included in the Top 10 of 2025 in this ranking.

Biologics drive demand for capable CDMOs across the pharmaceutical landscape. A well designed RFP process enables accurate proposals and stronger sponsor CDMO alignment. Comprehensive RFPs clarify scope timeline budget technologies and critical deliverables. Clear detail improves communication reduces risk and accelerates partner selection. Incomplete RFPs can delay selection technology transfer and damage early relationships.

Strong RFPs define project specifics responsibilities risks regulatory needs and partnership length. Input from executives experts and finance ensures realistic goals and expectations. Proposals should be compared on value expertise transparency and long term fit. Meetings and site visits validate capabilities capacity and cultural alignment. Investing in RFP quality increases success speed and market outcomes..

Prepared by:

Jakub Knurek

Marketing Specialist

j.knurek@mabion.eu

Jakub Knurek

Marketing Specialist

Jakub Knurek is a marketing and business development expert specializing in CDMO operations with scientific and biopharmaceutical background. During the COVID-19 pandemic, he contributed to the development of the Novavax protein vaccine. As a side project, he runs his own pharma company.

As the author of numerous articles, he is recognized as an important voice of the younger generation of scientists. He is a member of Mabion’s representation at industry trade shows, including BIO International Convention 2025 in Boston, 2nd Global Biologics India 2025 in Hydrabad, CPHI 2024 in Milan, CPHI 2023 in Barcelona, Life Sciences Baltics 2023 in Vilnius. He actively participates in academic, business and industry discussions, such as the “Building the Future Pharma Workforce” panel at CPHI Milan 2024.

Sources and further reading

1. Mabion. Optimize Your RFP To Ensure Successful Biologic Development. Outsourced Pharma. 2025.